<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjimph</journal-id><journal-id journal-id-type="pubmed">IARJIMPH</journal-id><journal-id journal-id-type="publisher">IARJIMPH</journal-id><issn>2709-331X</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iarjimph.2022.v03i01.016</article-id><title-group><article-title>Relation of Alpha Fetoprotein with HCV and HBV in Patients with Chronic Liver Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>NabilHamdy A.</given-names><surname>Boshnaq</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>MuhannadAbdullah</given-names><surname>Khalaf</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>MustafaMahir</given-names><surname>Khudur</surname></name></contrib></contrib-group><aff-id id="aff-a" /><abstract>Despite the fact that the hepatitis B virus (HBV) is the most common cause of hepatitis, the hepatitis C virus (HCV) is quickly becoming a serious infection that must be addressed. 1Hepatitis C virus (HCV) is a leading cause of acute and chronic liver disease. The purpose of this study was to determine the frequency of hepatitis B and C patients, as well as to determine whether elevated serum AFP levels were associated with hepatitis B and C infection. From the 19th of March 2021 to the 29th of June 2021, a cross-sectional study was carried out in the city of Kirkuk. There were 86 hepatitis B patients and 24 hepatitis C patients in the understudy for hepatitis. These patients were referred to the Hepatology and Gastroenterology centers in Kirkuk for treatment five milliliters of blood drawn through a vein puncture for determination of AFP, liver function tests, Hepatitis B surface Antigen (HBsAg), and hepatitis C antibody investigations were performed using blood samples. According to the results of the study, the mean AFP level in the study patients was 359 9.9 ng/mL, while the mean level in the controls was 1.93 0.24 ng/mL. When comparing the mean aspartate amino transferase activity to the mean control value, the difference was 145 1.8 u/L and 10.8 1.2 u/L, respectively. When measuring the activities of alanine amino transferase and alkaline phosphatase in the experimental subjects, the mean values were 75.51 and 176.1u/L and 171.6u/L, respectively, whereas in the control subjects, the mean values were 8.6 1.2u/L and 294.2u/L, respectively. The mean total bilirubin and mean direct bilirubin in the study subjects were 68.7 6.8 mol/L and 26.0 4.1 mol/L, respectively, whereas the mean total bilirubin and mean direct bilirubin in the control subjects were 10.6 1.2 mol/L and 4.2 1.0 mol/L, respectively. The mean total protein, albumin, and globulin concentrations were 50.6 3.6 g/L, 29.6 1.9 g/L, and 20.6 2.8 g/L, respectively, while the mean control values were 65.2 1.1 g/L, 42.1 1.1 g/L, and 21.9 1.2 g/L, respectively, in the same study. According to the findings, the mean AFP level in the 36 subjects who tested positive for HBsAg was 279 20 ng/mL, whereas the mean AFP level in CLD patients who tested positive for Hepatitis C antibody was 849 23 ng/mL, and the mean AFP level in those who tested negative for Hepatitis C virus was 16.3 3.6 ng/mL. The mean AFP level was highest (P 0.001) in CLD patients who had HCV infection, followed by those who had HBsAg positivity and those who did not have hepatitis infections.&amp;nbsp;Conclusions:&amp;nbsp;Serum AFP level was highest in CLD patients with HCV antibody positive compared to HBsAg positive CLD and hepatitis negative patients.</abstract></article-meta></front><body /><back /></article>